This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
10 - 14 June 2024
DoubleTree by Hilton Brussels CityBrussels, Belgium (Hybrid Event)

Patrick Fivey
Director of Precision Medicine Policy at AstraZeneca


Patrick Fivey is currently the Director of Precision Medicine Policy at AstraZeneca and is also a precision medicine representative at the European Federation of Pharmaceutical Industries and Associations (EFPIA) precision medicine working group, as well as regular input to the UK’s Association of British Pharmaceutical Industry (ABPI) task forces on regulatory affairs for diagnostics impacting precision medicines. Patrick has worked for several of the large pharmaceuticals companies over the last 29 years, mainly in UK marketing company roles. For the many of the last 16 years, his focus has been upon oncology precision medicines, particularly around reimbursement. In the last 4 years, his focus on precision medicines has been further refined, predominantly around the changing regulatory environment for companion diagnostics and IVDs needed for patient selection for use with precision medicines across both the EU and the UK. Especially the EU IVDR and UK MDR’s impact to precision medicines for both AstraZeneca, ABPI and EFPIA. He holds a degree in Molecular Biology and a MBA, in addition to a post graduate certificate in health economics.

Agenda Sessions

  • Multi-Stakeholder Panel: IVDR & The Transition Deadlines

  • Cross-Industry Learning: The Impact of IVDR on the Pharmaceutical Industry

  • IVDR Open Forum: Ask the Experts